XENETIC BIOSCIENCES, INC. Preferred Stock, Par or Stated Value Per Share
XENETIC BIOSCIENCES, INC. (XBIO) had Preferred Stock, Par or Stated Value Per Share of $0.00 per share as of 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Balance Sheet › Equity › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockParOrStatedValuePerShare · last filed 2016-11-14
- 2016-09-30: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2015-12-31: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2013-11-30: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2013-08-31: Preferred Stock, Par or Stated Value Per Share $0.00.
| Period end | Preferred Stock, Par or Stated Value Per Share |
|---|---|
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 |
| 2015-12-31 | $0.00 10-Q · filed 2016-11-14 |
| 2013-11-30 | $0.00 10-Q · filed 2014-01-10 |
| 2013-08-31 | $0.00 10-Q · filed 2014-01-10 |
| 2013-05-31 | $0.00 10-Q · filed 2013-07-17 |
| 2013-02-28 | $0.00 10-Q · filed 2013-04-22 |
| 2013-02-25 | $0.00 10-Q · filed 2014-01-10 |
| 2012-11-30 | $0.00 10-Q · filed 2013-01-22 |
| 2012-08-31 | $0.00 10-K · filed 2013-11-27 |
| 2012-05-31 | $0.00 10-Q · filed 2012-07-16 |
| 2011-08-31 | $0.00 10-K · filed 2012-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |